Shingles Vaccine Can Reduce Risk of Stroke And Heart Attack, Study Finds
Cardiovascular disease – involving the heart or blood vessels – is by far humanity's leading cause of death. It kills about 18 million people globally each year, mostly via heart attack or stroke.
While this is a daunting public health problem, medical science has revealed ways to lower risk: A heart-healthy diet helps, as do exercising daily, getting enough sleep, managing stress, and avoiding smoking.
According to the new study, covering data on more than 1.2 million people in South Korea over the age of 50, those who received a shingles vaccine showed a 23 percent lower risk of cardiovascular events overall.
This protection lasted for up to eight years, with the greatest reduction in risk observed two to three years after vaccination.
The effect was more pronounced in men, people younger than 60, and those with unhealthy behaviors such as smoking, drinking alcohol, or inactivity.
A shingles vaccination is already widely recommended for adults over 50 to protect against the viral disease, known for its painful skin rash and blisters.
Shingles is caused by the varicella-zoster virus – the culprit behind chickenpox. After people recover from chickenpox, typically in childhood, the virus can remain dormant in nerve cells for years or decades, then abruptly reactivate.
The immediate effects of shingles are bad enough, but while the rash usually fades in a few weeks, the disease can be insidiously persistent, explains pediatrician researcher Dong Keon Yon from Kyung Hee University in South Korea.
"Shingles causes a painful rash and can lead to serious complications, especially in older adults and those with weak immune systems," Yon says. "Research shows that, without vaccination, about 30 percent of people may develop shingles in their lifetime."
The most common complication is long-term nerve pain that can last for months or years. Shingles near the eyes can also lead to vision loss, and some people develop lasting neurological problems.
Recent research suggests shingles also raises stroke and heart attack risk. "In addition to the rash, shingles has been linked to a higher risk of heart problems, so we wanted to find out if getting vaccinated could lower this risk," Yon says.
The researchers merged data from several South Korean government agencies, ultimately studying more than 1.2 million people. Spanning 2012 to 2021, this included information on vaccination status as well as cardiovascular health and other relevant factors.
Vaccinated people had a 23 percent lower risk of cardiovascular events overall, including a 22 percent lower risk of coronary heart disease, a 26 percent lower risk of heart failure, and a 26 percent lower risk of a major cardiovascular event like stroke or heart attack.
"The shingles vaccine may help lower the risk of heart disease, even in people without known risk factors," Yon says.
That would be big news if confirmed, but makes sense given what we know about shingles' short-term effects on the cardiovascular system.
"A shingles infection can cause blood vessel damage, inflammation, and clot formation that can lead to heart disease," Yon explains. "By preventing shingles, vaccination may lower these risks."
One of the largest and most comprehensive of its kind, the study has some limitations, the authors acknowledge. The sample lacks diversity, since all subjects are from South Korea.
"While we conducted rigorous analysis, this study does not establish a direct causal relationship, so potential bias from other underlying factors should be considered," Yon says.
The study only addresses the live zoster vaccine, which uses a weakened form of the virus. There's also a recombinant subunit vaccine for shingles, featuring just a viral protein, that's increasingly prevalent in many countries.
In addition, previous research suggests both shingles vaccines may also protect against dementia.
The study was published in the European Heart Journal.
Spikes of Bird Flu in Cats Could Be a Warning of a Future Pandemic
HIV Drugs Dramatically Lower Risk of Alzheimer's Disease, Study Finds
Measles Could Become Endemic in US if Surge Continues, Expert Warns
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
7 hours ago
- Newsweek
Breastfeeding Reduces Risk of Early Puberty
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Kids who are exclusively breast-fed as infants are less likely to experience early puberty. This is the conclusion of South Korean researchers who studied the development and infant diets of more than 300,000 children. The team found that breastfeeding during the first four–six months of life was linked with a lower risk of so-called "central precocious puberty" (CPP) in both boys and girls. This association was partially mediated by differences in body weight throughout childhood, with childhood obesity linked to early pubertal onset. While it can lead to an early growth sport compared to other children, adults who went through early puberty tend to be shorter on average. CPP has also been linked to an increased risk of anxiety, depression and low self-esteem. Early puberty has also been associated with an increased risk of substance abuse, eating disorders and having sex at an early age. In women, early puberty is also known to increase the risk of breast cancer as adults. CPP has been on the rise globally, a trend that doctors Lin Yang and Shengxu Li—who were not involved in the study, but authored an accompanying comment paper—say is "particularly concerning given the growing prevalence of childhood obesity." The findings, the researchers note, add to the growing body of evidence highlighting the critical role of early-life nutrition in long-term health. A woman breastfeeds her newborn baby. A woman breastfeeds her newborn this nationwide, retrospective study, researchers compared the incidence of early puberty among children who were exclusively breastfed, formula-fed or mixed-fed during their first four to six months of life. Compared to exclusively breastfed children, formula-fed children had the greatest risk of CPP in boys and girls, followed by mixed-fed boys and girls. In their commentary paper, Yang and Li noted that the findings "contradict prior claims that breastfeeding is unrelated to the timing of pubertal onset in non-Western settings." They explained that the study's findings "suggest a potential developmental pathway through which infant feeding may influence early weight gain and the subsequent pubertal timing." However, they also acknowledged that the source of these associations remains uncertain, and that it is not yet clear whether excess body fat directly contributes to the activation of the hypothalamic-pituitary-gonadal axis—a hormonal pathway that regulates reproduction and development—or regulates upstream signals like the hypothalamic kisspeptin system, responsible for regulating the onset of puberty. The duo highlighted the study's importance in filling a research gap on puberty timing in boys. They noted: "Boys who were exclusively formula-fed had a 16 percent increased risk of CPP compared with those who were exclusively breastfed, and [excess body fat] mediated this association in a pattern similar to that observed in girls." The experts pointed out that this increase in CPP risk observed in boys contrasts with the 60 percent increase observed in girls—which might help explain the lack of similar reports on puberty timing in boys. Ultimately, the study's findings support the view that breastfeeding during early infancy may help protect against CPP in both sexes. As Yang and Li concluded: "Disease starts early, so should its prevention." Do you have a tip on a health story that Newsweek should be covering? Do you have a question about CPP? Let us know via health@ References Choe, Y., Ryu, S., Choi, J., Na, J. Y., Lee, K. S., Kim, Y. J., & Yang, S. (2025). Breastfeeding, prepubertal adiposity, and development of precocious puberty. JAMA Network Open, 8(8). Yang, L., & Li, S. (2025). Breastfeeding, adiposity, and precocious puberty in boys and girls. JAMA Network Open, 8(8).
Associated Press
15 hours ago
- Associated Press
GC Biopharma Signs MOU with Thai Red Cross Society to Strengthen Collaboration on Plasma-Derived Therapies
YONGIN, South Korea, Aug. 18, 2025 /PRNewswire/ -- GC Biopharma ( a South Korean biopharmaceutical company, announced today that it has signed a Memorandum of Understanding (MOU) with the Thai Red Cross Society (TRCS) to cooperate on workforce training for the production of plasma-derived medicinal products. This MOU formalizes and deepens a relationship that began in 2015, when GC Biopharma supported TRCS to establish a plasma fractionation facility in Thailand, and reflects the ongoing strategic collaboration between the two parties. Under the terms of the MOU, GC Biopharma and TRCS will jointly develop and operate on-site training and exchange programs for local production personnel. These programs aim to transfer GC Biopharma's advanced manufacturing technologies and expertise to support the development of local capabilities. In addition, both parties intend to continue identifying and expanding collaborative opportunities that align with their respective strengths and interests. The scope of cooperation will be gradually broadened to include potential joint projects such as the transfer of new processing technologies for plasma by-products and other strategic projects. 'This MOU is a significant step in broadening the reach of GC Biopharma's advanced technology and production standards across Asia,' said Hyoungjun Park, Vice President of GC Biopharma. 'Through our collaboration with the TRCS, we aim to achieve mutual growth while contributing to the public good.' 'Enhancing our personnel's capabilities through specialized training and direct knowledge transfer from GC Biopharma is essential to maintaining the quality, safety, and continuity of plasma-derived medicinal products production in Thailand,' said Assoc. Prof. Dootchai Chaiwanichsiri, Director of the National Blood Centre, TRCS. 'This collaboration not only supports the human resource development but also represents an important step for technology transfer and playing a vital role in strengthening the country's pharmaceutical and public health security.' Meanwhile, GC Biopharma continues to expand its global plasma-derived therapeutics business. In addition to entering the U.S. immunoglobulin market in 2024, the company is actively building partnerships in Southeast Asia, where domestic fractionation capabilities remain limited. About GC Biopharma GC Biopharma (formerly known as Green Cross Corporation) is a biopharmaceutical company headquartered in Yong-in, South Korea. The company has over half a century of experience in the development and manufacturing of plasma derivatives and vaccines, and is expanding its global presence with successful US market entry of Alyglo® (intravenous immunoglobulin G) in 2024. In line with its mission to meet the demands of future healthcare, GC Biopharma continues to drive innovation by leveraging its core R&D capabilities in engineering of proteins, mRNAs, and lipid nanoparticle (LNP) drug delivery platform to develop therapeutics for the field of rare disease as well as I&I (Immunology & Inflammation). To learn more about the company, visit This press release may contain biopharmaceuticals in forward-looking statements, which express the current beliefs and expectations of GC Biopharma's management. Such statements do not represent any guarantee by GC Biopharma or its management of future performance and involve known and unknown risks, uncertainties, and other factors. GC Biopharma undertakes no obligation to update or revise any forward-looking statement contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. GC Biopharma Contacts (Media) Sohee Kim [email protected] Yelin Jun [email protected] Yoonjae Na [email protected] View original content to download multimedia: SOURCE GC Biopharma
USA Today
3 days ago
- USA Today
I mentally unraveled. ChatGPT offered me tireless compassion.
Artificial intelligence shouldn't replace real mental health therapy. But it might be an option, particularly for teens like me who don't know where else to go. That winter of my high school freshman year, I unraveled. My stress levels skyrocketed. Despite my A-studded report card, I'd stare at an essay prompt for hours, paralyzed. I wasn't showering. I wasn't sleeping. At 1 a.m. or 2 a.m., I'd be awake, bingeing on webtoons. I wanted quick relief. I turned to ChatGPT. If you had asked me two years ago if I would use artificial intelligence for emotional support, I would have looked at you like you were an idiot. But, over time, I often found the only place where I could open up was AI. It has helped me deal with myself in my darkest moments, which shouldn't have been true. But it is. That's why even though I wouldn't recommend using ChatGPT specifically for mental health due to privacy concerns, I have come to think that AI has potential to be a mental support for teens like me, who don't feel comfortable talking to our friends or parents about our mental health. I still remember the time my sister practically begged my South Korean mother for a therapist, she started ranting about how only "crazy people" got therapists. I wasn't making the same mistake. Calling a crisis hotline seemed like overkill. I toyed with the idea of seeing my school therapist but decided against it. It felt too daunting to talk face-to-face with a therapist. Online options weren't much better. I was desperate. What the heck? I finally thought. ChatGPT can answer back, kinda like a therapist. Maybe I should try that out. 'You don't have to justify feeling this way' So I wrote to ChatGPT, an act which in itself felt cathartic. I wrote paragraphs of misspelled words, bumpy capitalization and unhinged grammar, fingers stumbling, writing about everything – how I couldn't stop reading webtoons, how much I hated school, hated life. I wrote in a way I would have only dared to write if only to a chatbot. In response, ChatGPT was tirelessly compassionate. 'I'm sorry you're dealing with that,' it'd start, and just seeing those words made me feel as if a weight had been lifted from my shoulders. Using ChatGPT as your therapist: How to make it work for you Soon, I even told ChatGPT how sometimes I was scared of my dad because of his biting sarcasm – something that I doubt I would have told a therapist about as quickly. ChatGPT responded by explaining that my fear was valid, that harm didn't just come physically but also emotionally. One line struck a chord in me: 'You don't have to justify feeling this way – it's real, and it matters.' Opinion alerts: Get columns from your favorite columnists + expert analysis on top issues, delivered straight to your device through the USA TODAY app. Don't have the app? Download it for free from your app store. It hit hard because I realized that's what I wanted to hear from my mom my entire life. To her credit, my mom tried. She'd give her best advice, usually something like, 'get over it.' As an immigrant who couldn't express her feelings in English, she learned to swallow them down. But even though I wanted to do the same, I couldn't. Oftentimes, awake at 2 a.m., I'd feel as if I were rotting. Yet somehow, the first thing to show me emotional intelligence wasn't a person – it was a chatbot. 'Thank you,' I remember writing to ChatGPT. 'I feel a lot calmer now.' Opinion: AI knows we shouldn't trust it for everything. I know because I asked it. Sometimes the best option is the one that's available Of course, there are critics who worry that turning to chatbots for emotional support might foster obsession and even exacerbate mental health issues. Honestly? I don't think artificial intelligence should be a replacement for real mental support systems. But the fear of using AI misses the bigger picture: Many teens don't have access to a "safe place." As of March, President Donald Trump revoked $11.4 billion in funding for mental health and addiction treatment. By July, his administration shut down a suicide hotline for LGBTQ+ youth, leaving countless teens stranded. Opinion: It will cost LGBTQ+ lives to shut down 988 suicide hotline. Unforgivable. According to Dr. Jessica Schleider, associate professor at Northwestern University, about 80% of teens with moderate to severe mental health conditions aren't able to get treatment. The reasons varied, but many reflected my own – not feeling our parents would take us seriously, worrying about stigma or cost. I am also not alone in my use of ChatGPT: 28% of parents report their children using AI for emotional support. Yes, instead of turning to a trusted therapist or adult, these children were finding real comfort in bots. In a 2024 YouGov survey, 50% of participants said the 24/7 availability of these chatbots was helpful for mental health purposes. However questionable, sometimes the best option is to turn to the only resource for teens that is available: artificial intelligence. I know for a fact that it's helped me. I can only hope it can help others. If you or someone you know needs mental health resources and support, please call, text or chat with the 988 Suicide & Crisis Lifeline or visit for 24/7 access to free and confidential services. Elizabeth Koo is a student at the Kinkaid School in Houston with a passion for storytelling and a keen interest in culture, technology and education. You can read diverse opinions from our USA TODAY columnists and other writers on the Opinion front page, on X, formerly Twitter, @usatodayopinion and in our Opinion newsletter.
